GenScript Biotech

Genscript Biotech Corporation is a global biotech company. The Company’s mission is to “Make the Human and Nature Healthier through Biotechnology”. Genscript Biotech Corporation is a leading life sciences research and application service and product provider that applies its proprietary technology to various fields from basic life sciences research to translational biomedical development, industrial synthetic products, and cell therapeutic solutions. Leveraging in the Group’s proprietary gene synthesis and other technology and know-hows, the Group has established four major platforms including (i) a leading contracted research organization (“CRO”) platform to provide one-stop solutions to global research communities; (ii) a contract development and manufacturing organization (“CDMO”) platform; (iii) an industrial synthetic products platform; and (iv) an integrated global cell therapy platform. The CRO platform remains as the strong and stable revenue generating foundation for the entire corporate. The CDMO platform provides end-to-end biologics discovery and development services to pharmaceutical, biotech, government and academic customers worldwide. The industrial synthetic products platform develops products for food and feed processing and other industrial uses. The cell therapy platform provides cell therapy solutions to patients with refractory diseases including cancer and inflammatory diseases. Backed by gene synthesis and editing technology, the Group has made significant progress in its synthetic biology research and application, which mainly materialized into its innovative chimeric antigen receptor (“CAR”) T-cell (“CAR-T”) therapy and industrial enzyme businesses. With a strong sales and marketing team and strong research and development capabilities, the Company maintains a stable and sustainable growth.

Lab Information

GenScript Biotech

Research Area and Skills

Recognize this scientist’s Expertise for their contribution in your research

Cell therapy 1 Immuno-oncology 1 Immunology 1 Molecular Biology 0 Oligo 0 Protein 0 Peptide 0

More

  • Post
  • Publication
  • Plasmid
  • Following (4)
  • Follower (4)

The relationship between #SARSCoV2 #vaccines and #neutralizingantibodies was evaluated to determine vaccine efficacy by using cPass, the only FDA authorized assay for NAbs detection. Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142841/ Learn more about cPass: ...Learn More


Alzheimer’s disease is a progressive neurodegenerative condition and the leading cause of dementia in the elderly worldwide. The World Health Organization (WHO) estimates that of 50 million individuals who have dementia globally, 60-70% have Alzheimer’s disease. Loss of ...Learn More


The COVID-19 pandemic has emerged as a catastrophic global emergency. The recent dramatic appearance of variants of concern of SARS-coronavirus-2 (SARS-CoV-2) highlights the need for innovative approaches that simultaneously suppress viral replication and circumvent viral escape ...Learn More


Why are rabbit antibodies a sought-after tool?From analytical applications (e.g., Western blot, ELISA, and Immunostaining) to diagnostics (e.g., detection of tumor-associated antigens: PDL-1, estrogen receptor, and HER2) and even as therapeutics (e.g., Brolucizumab, Eptinezumab), ...Learn More


SummaryThe development of numerous vaccines against SARS-CoV-2 worldwide within one year of the pandemic is unprecedented and undoubtedly a huge accomplishment in human history. But some of the emerging mutated SARS-CoV-2 variants can go around the antibody defenses established by ...Learn More



This guy hasn’t publications anything yet.

Cloud Scientists

About Us · User Accounts and Benefits · Privacy Policy · Management Center · FAQs
© 2021 MolecularCloud